GLEEVEC: payments to doctors
Payments that named GLEEVEC as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $342K
- Providers
- 68
- Transactions
- 275
- Average per transaction
- $1,244
The per-transaction average — $1,244 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 68 providers the average total is $5,030, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Novartis | $223,960 | 65.5% |
| Novartis Pharma AG | $118,093 | 34.5% |